The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 2)
Open accessAbstract
The zeta potential (ZP) of colloidal systems and nano-medicines, as well as their particle size exert a major effect on the various properties of nano-drug delivery systems. Not only the stability of dosage forms and their release rate are affected but also their circulation in the blood stream and absorptioninto body membranes are dramatically altered by ZP. In this paper the effect of ZP on the various properties of nano-medicines are reviewed. Furthermore, the ability of employing zeta potential to target drug delivery systems to, and drug release at specific sites of the body are discussed.Keywords: Nano-medicines, Zeta potential, Drug targeting, Site-specific release, Dosage form stability
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Nishiyama, N., & Kataoka, K. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.006 · Cited by 1,052
Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential
Patil, S., Sandberg, A., Heckert, E., Self, W., & Seal, S. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.07.029 · Cited by 1,044
Recent progress in tumor pH targeting nanotechnology
Lee, E. S., Gao, Z., & Bae, Y. H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.003 · Cited by 866
Advances in polymeric micelles for drug delivery and tumor targeting
Kedar, U., Phutane, P., Shidhaye, S., & Kadam, V. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.05.005 · Cited by 791
Bawarski, W. E., Chidlowsky, E., Bharali, D. J., & Mousa, S. A. (2008) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.06.002 · Cited by 337
Therapeutic applications of colloidal drug carriers
Barratt, G. M. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00255-8 · Cited by 282
Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin
Kim, J. O., Kabanov, A. V., & Bronich, T. K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.019 · Cited by 255
Pan, J., & Feng, S.-S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.10.039 · Cited by 238
Drug physical state and drug–polymer interaction on drug release from chitosan matrix films
Puttipipatkhachorn, S., Nunthanid, J., Yamamoto, K., & Peck, G. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00389-3 · Cited by 236
Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide
Jacobs, C., Kayser, O., & Müller, R. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00412-3 · Cited by 232
Lee, S.-Y., Huh, M. S., Lee, S., Lee, S. J., Chung, H., Park, J. H., Oh, Y.-K., Choi, K., Kim, K., & Kwon, I. C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.007 · Cited by 183
Hoeller, S., Sperger, A., & Valenta, C. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.11.014 · Cited by 179
Multifunctional Nanoparticulate Polyelectrolyte Complexes
Hartig, S. M., Greene, R. R., Dikov, M. M., Prokop, A., & Davidson, J. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9459-1 · Cited by 167
Recent Advances and Patents on Solid Lipid Nanoparticles
Sawant, K. K., & Dodiya, S. S. (2008) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221108784534081 · Cited by 158
The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles
Lee, A. L. Z., Wang, Y., Cheng, H. Y., Pervaiz, S., & Yang, Y. Y. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.10.062 · Cited by 157
Makhlof, A., Werle, M., Tozuka, Y., & Takeuchi, H. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.001 · Cited by 137
The performance of nanocarriers for transmucosal drug delivery
Csaba, N., García-Fuentes, M., & Alonso, M. J. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.4.463 · Cited by 127
Chitosan-coated liposomes for delivery to lungs by nebulisation
Zaru, M., Manca, M. L., Fadda, A. M., & Antimisiaris, S. G. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.01.010 · Cited by 123
Beck‐Broichsitter, M., Ruppert, C., Schmehl, T., Guenther, A., Betz, T., Bakowsky, U., Seeger, W., Kissel, T., & Gessler, T. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.10.007 · Cited by 116
Prolonged gene silencing by combining siRNA nanogels and photochemical internalization
Raemdonck, K., Naeye, B., Høgset, A., Demeester, J., & Smedt, S. C. D. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.012 · Cited by 106
Cai, C., Bakowsky, U., Rytting, E., Schaper, A., & Kissel, T. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.10.005 · Cited by 96
Harush-Frenkel, O., Bivas‐Benita, M., Nassar, T., Springer, C., Sherman, Y., Avital, A., Altschuler, Y., Borlak, J. T., & Benita, S. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.04.011 · Cited by 89
Fabrication and characterizations of a novel drug delivery device liposomes-in-microsphere (LIM)
Feng, S., Ruan, G., & Li, Q. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.12.013 · Cited by 83
Unger, F., Wittmar, M., & Kissel, T. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.12.002 · Cited by 79
The encapsulation of DNA molecules within biomimetic lipid nanocapsules
Vonarbourg, A., Passirani, C., Desigaux, L., Allard-Vannier, É., Saulnier, P., Lambert, O., Benoît, J., & Pitard, B. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.009 · Cited by 71
Wang, J., Feng, S., Wang, S., & Chen, Z.-Y. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.08.026 · Cited by 69
Layer-by-layer polyelectrolyte coating of low molecular weight poly(lactic acid) nanoparticles
Hirsjärvi, S., Peltonen, L., & Hirvonen, J. J. (2006) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2006.03.009 · Cited by 45
Preparation and pharmacokinetics of pirarubicin loaded dehydration–rehydration vesicles
Kawano, K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00628-2 · Cited by 28
Formulation and characterization of doxorubicin nanovesicles
Honary, S., Ebrahimi, P., Tabbakhian, M., & Zahir, F. (2009) · Journal of Vacuum Science & Technology B Microelectronics and Nanometer Structures Processing Measurement and Phenomena · doi:10.1116/1.3127504 · Cited by 13
Self-citation
Cited by
Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology
Zielińska, A., Carreiró, F., Oliveira, A. M., Neves, A., Pires, B., Venkatesh, D. N., Durazzo, A., Lucarini, M., Eder, P., Silva, A. M., et al. (2020) · Molecules · doi:10.3390/molecules25163731 · Cited by 1,560
Ghezzi, M., Pescina, S., Padula, C., Santi, P., Del Favero, E., Cantù, L., & Nicoli, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.031 · Cited by 1,135
Pateiro, M., Gómez, B., Munekata, P. E. S., Barba, F. J., Putnik, P., Kovačević, D. B., & Lorenzo, J. M. (2021) · Molecules · doi:10.3390/molecules26061547 · Cited by 595
Alshawwa, S. Z., Kassem, A. A., Farid, R. M., Mostafa, S. K., & Labib, G. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040883 · Cited by 531
Yanat, M., & Schroën, K. (2021) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2021.104849 · Cited by 457
Metadata
- Authors
- Honary, S., & Zahir, F.
- Venue
- Tropical Journal of Pharmaceutical Research
- Publisher
- African Journals Online (AJOL)
- Published
- 2013-05-09
- Volume
- 12
- Issue
- 2
- ISSN
- 1596-5996 (ISSN-L)
- 1596-9827
- OpenAlex
- W4234509136
- Cited by
- 1,309
- References
- 30
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.